Oxurion NV (XBRU:OXUR) Other Gross PPE : €0.03 Mil (As of Dec. 2023)

View and export this data going back to 2006. Start your Free Trial

What is Oxurion NV Other Gross PPE?

Oxurion NV's Other Gross PPE for the quarter that ended in Dec. 2023 was €0.03 Mil.

Oxurion NV's quarterly Other Gross PPE increased from Dec. 2022 (€0.11 Mil) to Jun. 2023 (€1.13 Mil) but then declined from Jun. 2023 (€1.13 Mil) to Dec. 2023 (€0.03 Mil).

Oxurion NV's annual Other Gross PPE declined from Dec. 2021 (€0.15 Mil) to Dec. 2022 (€0.11 Mil) and declined from Dec. 2022 (€0.11 Mil) to Dec. 2023 (€0.03 Mil).

Oxurion NV Other Gross PPE Historical Data

The historical data trend for Oxurion NV's Other Gross PPE can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Oxurion NV Other Gross PPE Chart

Oxurion NV Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Gross PPE

Get a 7-Day Free Trial

0.39

1.07

0.15

0.11

0.03

Oxurion NV Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Other Gross PPE	Get a 7-Day Free Trial															0.15	1.18	0.11	1.13	0.03

Oxurion NV Other Gross PPE Calculation

GuruFocus lists Land And Improvements, Buildings And Improvements, Machinery, Furniture, Equipment, Construction In Progress and Other Gross PPE under the "Gross Property, Plant and Equipment" section.

Oxurion NV (XBRU:OXUR) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Oxurion NV (XBRU:OXUR) » Definitions » Other Gross PPE

Comparable Companies

Traded in Other Exchanges

TG4:Germany

Address

Gaston Geenslaan 1, Leuven, BEL, B-3001

Website

https://www.oxurion.com

Oxurion NV is a clinical stage biopharmaceutical company developing next generation standard of care ophthalmic therapies, which are designed to improve and better preserve vision in patients with retinal disorders including diabetic macular edema (DME). The Group's research and development facilities are located in Belgium .The Company is engaged in the development of drugs to treat back-of-the-eye diseases, more specifically, ophthalmologic pharmaceuticals to treat vascular retinal disorders, specifically DME.

Oxurion NV (XBRU:OXUR) Headlines

No Headlines